Author:
Gonzalez Bosquet Jesus,Newtson Andreea M.,Chung Rebecca K.,Thiel Kristina W.,Ginader Timothy,Goodheart Michael J.,Leslie Kimberly K.,Smith Brian J.
Funder
National Cancer Institute
Foundation for Women's Cancer
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Medicine
Reference57 articles.
1. American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.
2. Gilks CB, Prat J. Ovarian carcinoma pathology and genetics: recent advances. Hum Pathol. 2009;40:1213–23.
3. Cannistra SA. Cancer of the ovary. N Engl J Med. 2004;351:2519–9.
4. Friedlander ML, Stockler MR, Butow P, King MT, McAlpine J, Tinker A, Ledermann JA. Clinical trials of palliative chemotherapy in platinum-resistant or -refractory ovarian cancer: time to think differently? J Clin Oncol. 2013;31:2362.
5. Johnson SW, Laub PB, Beesley JS, Ozols RF, Hamilton TC. Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines. Cancer Res. 1997;57:850–6.
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献